XML 43 R86.htm IDEA: XBRL DOCUMENT v2.4.1.9
Segment Information (Net Revenues Classified Based on Therapeutic Product Categories) (Details) (USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Product Information [Line Items]      
Net sales $ 7,646.5us-gaap_SalesRevenueGoodsNet $ 6,856.6us-gaap_SalesRevenueGoodsNet $ 6,750.2us-gaap_SalesRevenueGoodsNet
Allergy      
Product Information [Line Items]      
Net sales 1,017.5us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_AllergyMember
850.2us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_AllergyMember
741.5us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_AllergyMember
Anti-infectives      
Product Information [Line Items]      
Net sales 1,264.4us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_AntiInfectiveAgentsMember
1,080.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_AntiInfectiveAgentsMember
1,034.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_AntiInfectiveAgentsMember
Cardiovascular      
Product Information [Line Items]      
Net sales 955.9us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_CardiovascularMember
1,162.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_CardiovascularMember
1,156.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_CardiovascularMember
Central Nervous System      
Product Information [Line Items]      
Net sales 1,318.6us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_CentralNervousSystemMember
1,393.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_CentralNervousSystemMember
1,473.9us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_CentralNervousSystemMember
Dermatological      
Product Information [Line Items]      
Net sales 223.8us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_DermatologicalMember
247.9us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_DermatologicalMember
157.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_DermatologicalMember
Endocrine and Metabolic      
Product Information [Line Items]      
Net sales 778.7us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_EndocrineAndMetabolicMember
568.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_EndocrineAndMetabolicMember
645.9us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_EndocrineAndMetabolicMember
Gastrointestinal      
Product Information [Line Items]      
Net sales 344.6us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_GastrointestinalMember
365.8us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_GastrointestinalMember
418.9us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_GastrointestinalMember
Renal and Genitourinary Agents      
Product Information [Line Items]      
Net sales 609.5us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_RenalandGenitourinaryAgentsMember
191.1us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_RenalandGenitourinaryAgentsMember
164.8us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_RenalandGenitourinaryAgentsMember
Respiratory System      
Product Information [Line Items]      
Net sales 252.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_RespiratoryAgentsMember
259.7us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_RespiratoryAgentsMember
229.3us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_RespiratoryAgentsMember
Other      
Product Information [Line Items]      
Net sales $ 881.2us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_OtherProductsMember
[1] $ 737.7us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_OtherProductsMember
[1] $ 728.0us-gaap_SalesRevenueGoodsNet
/ us-gaap_ProductOrServiceAxis
= myl_OtherProductsMember
[1]
Net Revenues      
Product Information [Line Items]      
Therapeutic class disclosure threshold 5.00%myl_TherapeuticClassReportingThreshold
/ us-gaap_InformationByFinancialStatementLineItemAxis
= us-gaap_SalesRevenueGoodsNetMember
5.00%myl_TherapeuticClassReportingThreshold
/ us-gaap_InformationByFinancialStatementLineItemAxis
= us-gaap_SalesRevenueGoodsNetMember
5.00%myl_TherapeuticClassReportingThreshold
/ us-gaap_InformationByFinancialStatementLineItemAxis
= us-gaap_SalesRevenueGoodsNetMember
[1] (1) Other consists of numerous therapeutic classes, none of which individually exceeds 5% of consolidated net sales.